Effect of Variation inCHI3L1on Serum YKL-40 Level, Risk of Asthma, and Lung Function
Author(s) -
Carole Ober,
Zheng Tan,
Ying Sun,
Jennifer D. Possick,
Lin Pan,
Raluca Nicolae,
Sadie Radford,
Rodney Parry,
Andrea Heinzmann,
Klaus A. Deichmann,
Lucille A. Lester,
James E. Gern,
Robert F. Lemanske,
Dan L. Nicolae,
Jack A. Elias,
Geoffrey Chupp
Publication year - 2008
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa0708801
Subject(s) - asthma , medicine , single nucleotide polymorphism , snp , population , cohort , immunology , bronchial hyperresponsiveness , lung , respiratory disease , genotype , biology , gene , genetics , environmental health
The chitinase-like protein YKL-40 is involved in inflammation and tissue remodeling. We recently showed that serum YKL-40 levels were elevated in patients with asthma and were correlated with severity, thickening of the subepithelial basement membrane, and pulmonary function. We hypothesized that single-nucleotide polymorphisms (SNPs) that affect YKL-40 levels also influence asthma status and lung function.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom